Latest Articles

Publication Date
Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification - MMJDaily

Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification MMJDaily

Published: May 1, 2026, 12:50 p.m.
Companies with cannabis-based drugs eye IPOs, private funding boost after U.S. reclassification - BNN Bloomberg

Companies with cannabis-based drugs eye IPOs, private funding boost after U.S. reclassification BNN Bloomberg

Published: April 30, 2026, 3:10 p.m.
The Molecular Classification Ushers in a New Era for the Treatment of Advanced and Recurrent Endometrial Cancer - Frontiers

The Molecular Classification Ushers in a New Era for the Treatment of Advanced and Recurrent Endometrial Cancer Frontiers

Published: Dec. 18, 2025, 3:05 p.m.
Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer - Nature

Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer Nature

Published: Oct. 14, 2025, 4:47 p.m.
Can IVIM MRI be superior to ADC in predicting aggressive subtypes of endometrial carcinoma: new insights into FIGO 2023 classification - SpringerOpen

Can IVIM MRI be superior to ADC in predicting aggressive subtypes of endometrial carcinoma: new insights into FIGO 2023 classification SpringerOpen

Published: Oct. 10, 2025, 6:31 a.m.
High-grade serous carcinomas identified in cervical biopsies: A clinicopathologic study supporting the exclusion of cervical serous carcinoma from World Health Organization classification - EurekAlert!

High-grade serous carcinomas identified in cervical biopsies: A clinicopathologic study supporting the exclusion of cervical serous carcinoma from World Health Organization classification EurekAlert!

Published: Sept. 8, 2025, 5:37 p.m.
(PDF) Nomogram Incorporating Inflammatory Index, Pathology, and Molecular Classification for Predicting Recurrence in Patients with Stage I-III Endometrial Cancer: A Multi-Institutional Study - researchgate.net

(PDF) Nomogram Incorporating Inflammatory Index, Pathology, and Molecular Classification for Predicting Recurrence in Patients with Stage I-III Endometrial Cancer: A Multi-Institutional Study researchgate.net

Published: Aug. 7, 2025, 4:27 p.m.
Mapping Deep Endometriosis in Patients with Ovarian Endometriomas according to the #Enzian Classification: A Single-Centre Retrospective Analysis - Frontiers

Mapping Deep Endometriosis in Patients with Ovarian Endometriomas according to the #Enzian Classification: A Single-Centre Retrospective Analysis Frontiers

Published: July 3, 2025, 9:55 a.m.
Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification - Nature

Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification Nature

Published: May 20, 2025, 7:23 p.m.
The association of molecular classification with fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma:A retrospective study - Frontiers

The association of molecular classification with fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma:A retrospective study Frontiers

Published: March 24, 2025, 4:03 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!